UEEC · United Health Products, Inc.
$0.05
+0.00 (+0.00%)
At close · Jul 21
Going-concern doubt
— flagged May 15, 2026
Substantial doubt about the company's ability to continue as a going concern.
“In view of these matters, there is substantial doubt about the Company's ability to continue as a going concern.”View the 10-Q filed May 15, 2026
Market Cap
$11.72M
Shares
260.39M
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$0
FY2025
Net Income
-$2.67M
-33.4%
FY2025
Gross Margin
50.28%
-7.4pp
FY2022
Operating Margin
-7472.1%
+50502078.8pp
FY2022
Diluted EPS
-$0.01
0%
FY2025
Operating Cash Flow
-$1.19M
+0.7%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $0 | $0 | $0 | $0 | $37.5K | $59 | $643 | $4927 | $45.86K | $645.65K | $242.01K | $53.27K | $162.68K | $3060 | — | $69.07K | |
| — | — | — | $0 | $18.64K | $25 | $195 | $1316 | $96.7K | $67.02K | $117.93K | $27.51K | $82.96K | — | — | $56.45K | |
| — | — | — | $0 | $18.86K | $34 | $448 | $3611 | -$50.84K | $578.64K | $124.08K | $25.75K | $79.71K | — | — | — | |
| — | — | — | — | 50.28% | 57.63% | 69.67% | 73.29% | -110.85% | 89.62% | 51.27% | 48.35% | 49% | — | — | — | |
| $166.18K | $269.87K | $355.94K | $598.81K | $624.56K | $237.46K | $245.22K | $666.39K | $76.95K | — | — | — | — | — | — | — | |
| $4.83M | — | — | — | — | — | — | — | $2.25M | $1.3M | $641.55K | $2.61M | $2.12M | $1.22M | $107.02K | $1.22M | |
| $865.66K | $1.99M | $1.65M | $1.83M | $2.2M | $29.56M | $14.6M | $5.43M | — | — | — | — | — | — | — | — | |
| — | — | — | — | — | — | — | — | — | — | — | $50K | $50K | $100K | $100K | $100K | |
| — | $4050 | $4050 | $4050 | — | — | — | — | — | — | — | — | $50K | — | — | — | |
| $1.03M | $2.26M | $2.01M | $2.43M | $2.82M | $29.8M | $14.85M | $6.1M | $2.33M | $1.3M | $641.55K | $2.61M | — | — | — | — | |
| -$1.03M | -$2.26M | -$2.01M | -$2.43M | -$2.8M | -$29.8M | -$14.85M | -$6.09M | -$2.38M | -$719.32K | -$517.48K | -$2.58M | -$2.09M | -$1.32M | -$207.02K | -$1.32M | |
| — | — | — | — | -7472.1% | -50509550.85% | -2309276.98% | -123688.09% | -5184.18% | -111.41% | -213.83% | -4848.71% | -1286.1% | -43029.64% | — | -1907.33% | |
| — | -$2.25M | -$2M | -$2.42M | — | — | — | — | — | — | — | — | -$2.04M | — | — | — | |
| — | — | — | $40.51K | $17.02K | $226.14K | $210.03K | $508.18K | $31K | $31K | $18.26K | $9147 | $52.15K | -$68.7K | $74.4K | $270.95K | |
| -$421.69K | -$413.87K | $5839 | -$196.73K | $1.11M | -$748.55K | -$862.75K | -$508.18K | -$3.63M | -$215.65K | -$18.26K | -$9147 | -$52.15K | — | — | — | |
| — | — | — | — | — | — | — | $0 | — | — | — | — | — | — | — | -$180K | |
| — | $0 | $0 | $0 | $0 | $0 | $0 | $0 | — | — | — | — | — | — | — | — | |
| -$1.45M | -$2.67M | -$2M | -$2.62M | -$1.69M | -$30.55M | -$15.71M | -$6.6M | -$6.01M | -$934.97K | -$535.74K | -$2.59M | -$2.14M | -$1.13M | -$281.41K | -$1.59M | |
| — | — | — | — | -4500% | -51778276.27% | -2443452.57% | -134002.33% | -13096.1% | -144.81% | -221.37% | -4865.88% | -1318.15% | -36809.35% | — | -2299.61% | |
| USD/shares | — | — | — | — | — | — | — | — | -$0.04 | -$0.01 | $0.00 | -$0.02 | — | — | — | — |
| USD/shares | — | -$0.01 | -$0.01 | — | — | — | — | — | — | — | — | — | — | — | — | — |
| shares | — | — | — | — | — | — | 183.76M | 175.88M | — | — | — | — | — | — | — | — |
| shares | — | 256.98M | 248.17M | — | — | — | 183.76M | 175.88M | — | — | — | — | — | — | — | — |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Capital Returned to Shareholders
Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2022–FY2023: $50K in buybacks.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against the industry, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
—
Medical Instruments & Supplies median 2.10×
EV/EBIT
—
Medical Instruments & Supplies median 28.56×
P/E (TTM)
—
Medical Instruments & Supplies median 36.99×